Shanghai ZJ Bio-Tech Co., Ltd (SHA:688317)

Shanghai ZJ Bio-Tech Cash Flow Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Income	-127.46	-136.86	760.27	758.52
Depreciation & Amortization	67.71	66.69	60.24	24.84
Other Amortization	1.42	0.59	0.08	-
Loss (Gain) From Sale of Assets	-0.04	-	-0.03	-
Asset Writedown & Restructuring Costs	22.53	1.15	0.59	0.03
Loss (Gain) From Sale of Investments	-0.06	-	-	-
Provision & Write-off of Bad Debts	8.41	1.36	6.35	5.38
Other Operating Activities	134.73	169.99	-62.76	28.33
Change in Accounts Receivable	37.31	114.77	12.17	-25.19
Change in Inventory	36.37	31.72	-297.19	-172.51
Change in Accounts Payable	-81.05	-304.21	104.49	16.72
Change in Other Net Operating Assets	0.98	0.61	1.18	5.86
Operating Cash Flow	77.59	-81.88	584.97	641.94
Operating Cash Flow Growth	-	-	-8.87%	-43.78%
Capital Expenditures	-19.49	-81.15	-74.56	-498.06
Sale of Property, Plant & Equipment	0.01	1.14	0.06	-
Investment in Securities	0.06	2.32	-1.53	-21
Investing Cash Flow	-19.42	-77.69	-76.02	-519.06
Long-Term Debt Repaid	-2.51	-3.65	-3.75	-
Net Debt Issued (Repaid)	-2.51	-3.65	-3.75	-
Issuance of Common Stock	-	-	-	1,959
Repurchase of Common Stock	-35.33	-	-102.03	-
Common Dividends Paid	-20.88	-230.74	-265.62	-311.53
Other Financing Activities	-	-	-	-19.3
Financing Cash Flow	-58.72	-234.39	-371.4	1,628
Foreign Exchange Rate Adjustments	14.44	15.77	74.35	-19.82
Net Cash Flow	13.89	-378.19	211.9	1,731
Free Cash Flow	58.1	-163.03	510.41	143.88
Free Cash Flow Growth	-	-	254.76%	-86.52%
Free Cash Flow Margin	32.52%	-59.43%	21.94%	7.13%
Free Cash Flow Per Share	0.30	-0.85	2.64	0.76
Cash Income Tax Paid	17.21	52.97	188.93	261.3
Levered Free Cash Flow	42.13	-98.85	410.82	-144.71
Unlevered Free Cash Flow	42.35	-98.63	411.11	-144.71
Change in Working Capital	-29.64	-184.81	-179.76	-175.17

Source: S&P Global Market Intelligence. Standard template. Financial Sources.